Mgr. Karla Plevová, Ph.D.

2017

• KANTOROVA, B; MALCIKOVA, J; BRAZDILOVA, K; BORSKY, M; PLEVOVA, K; SMARDOVA, J; RADOVA, L; TOM, N; TRBUSEK, M; DIVISKOVA, E; FRANCOVA, HS; NAVRKALOVA, V; DOUBEK, M; BRYCHTOVA, Y; MAYER, J; POSPISILOVA, S, 2017:Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY 178 (6), p. 979 - 982.
• KOTASKOVA, J; PAVLOVA, S; PLEVOVA, K; MALCIKOVA, J; STEHLIKOVA, O; POPPOVA, L; KOCKOVA, H; DOUBEK, M; BRYJA, V; POSPISILOVA, S, 2017:TREATMENT WITH BCR INHIBITORS INCREASES ROR1 EXPRESSION IN CLL CELLS. HAEMATOLOGICA 102 , p. 414 - 414.
• PLEVOVA, K; MALCIKOVA, J; PAVLOVA, S; KOTASKOVA, J; POPPOVA, L; SMARDOVA, J; DIVISKOVA, E; DURECHOVA, K; OLTOVA, A; BRYCHTOVA, Y; PANOVSKA, A; DOUBEK, M; POSPISILOVA, S, 2017:BIALLELIC TP53 GENE MUTATIONS DUE TO COPY-NEUTRAL LOSS OF HETEROZYGOSITY AND MONOALLELIC MUTATIONS IN ABSENCE OF 17P DELETION OCCUR IN CLL WITH COMPARABLE FREQUENCY. HAEMATOLOGICA 102 , p. 65 - 66.
• YOUNG, E; NOERENBERG, D; MANSOURI, L; LJUNGSTROM, V; FRICK, M; SUTTON, LA; BLAKEMORE, SJ; GALAN-SOUSA, J; PLEVOVA, K; BALIAKAS, P; ROSSI, D; CLIFFORD, R; ROOS-WEIL, D; NAVRKALOVA, V; DORKEN, B; SCHMITT, CA; SMEDBY, KE; JULIUSSON, G; GIACOPELLI, B; BLACHLY, JS; BELESSI, C; PANAGIOTIDIS, P; CHIORAZZI, N; DAVI, F; LANGERAK, AW; OSCIER, D; SCHUH, A; GAIDANO, G; GHIA, P; XU, W; FAN, L; BERNARD, OA; NGUYEN-KHAC, F; RASSENTI, L; LI, J; KIPPS, TJ; STAMATOPOULOS, K; POSPISILOVA, S; ZENZ, T; OAKES, CC; STREFFORD, JC; ROSENQUIST, R; DAMM, F, 2017:EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. LEUKEMIA 31 (7), p. 1547 - 1554.

2016

• BALIAKAS, P; MATTSSON, M; HADZIDIMITRIOU, A; MINGA, E; AGATHANGELIDIS, A; SUTTON, LA; SCARFO, L; DAVIS, Z; YAN, XJ; PLEVOVA, K; SANDBERG, Y; VOJDEMAN, FJ; TZENOU, T; CHU, CC; VERONEZE, S; MANSOURI, L; SMEDBY, KE; GIUDICELLI, V; NGUYEN-KHAC, F; PANAGIOTIDIS, P; JULIUSSON, G; ANAGNOSTOPOULOS, A; LEFRANC, MP; TRENTIN, L; CATHERWOOD, M; MONTILLO, M; NIEMANN, CU; LANGERAK, AW; POSPISILOVA, S; STAVROYIANNI, N; CHIORAZZI, N; OSCIER, D; JELINEK, DF; SHANAFELT, T; DARZENTAS, N; BELESSI, C; DAVI, F; GHIA, P; ROSENQUIST, R; STAMATOPOULOS, K, 2016:NO IMPROVEMENT IN LONG-TERM OVERALL SURVIVAL AFTER THE INTRODUCTION OF CHEMO(IMMUNO)THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS BELONGING TO STEREOTYPED SUBSET #2. HAEMATOLOGICA 101 , p. 231 - 231.
• HERNANDEZ-SANCHEZ, M; RADOVA, L; KOTASKOVA, J; TAMBORERO, D; RODRIGUEZ, AE; PLEVOVA, K; ABAIGAR, M; BIKOS, V; BENITO, R; TAKACOVA, S; QUIJADA, M; MARTIN, AA; ALCOCEBA, M; DE COCA, AG; DOUBEK, M; GONZALEZ, M; LOPEZ-BIGAS, N; POSPISILOVA, S; HERNANDEZ-RIVAS, JM, 2016:Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing. BLOOD 128 (22)
• JANOVSKA, P; POPPOVA, L; PLEVOVA, K; PLESINGEROVA, H; BEHAL, M; KAUCKA, M; OVESNA, P; HLOZKOVA, M; BORSKY, M; STEHLIKOVA, O; BRYCHTOVA, Y; DOUBEK, M; MACHALOVA, M; BASKAR, S; KOZUBIK, A; POSPISILOVA, S; PAVLOVA, S; BRYJA, V, 2016:Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. CLINICAL CANCER RESEARCH 22 (2), p. 459 - 469.
• KOPPARAPU, PK; BHOI, S; MANSOURI, L; ARABANIAN, LS; PLEVOVA, K; POSPISILOVA, S; WASIK, AM; CROCI, GA; SANDER, B; PAULLI, M; ROSENQUIST, R; KANDURI, M, 2016:Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression. EPIGENETICS 11 (5), p. 335 - 343.
• KOTASKOVA, J; PAVLOVA, S; GREIF, I; STEHLIKOVA, O; PLEVOVA, K; JANOVSKA, P; BRYCHTOVA, Y; DOUBEK, M; POSPISILOVA, S; BRYJA, V, 2016:ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells. BRITISH JOURNAL OF HAEMATOLOGY 175 (2), p. 339 - 342.
• KUBESOVA, B; PAVLOVA, S; MALCIKOVA, J; KABATHOVA, J; RADOVA, L; TOM, N; TICHY, B; PLEVOVA, K; KANTOROVA, B; FIEDOROVA, K; KISSOVA, J; GISSLINGER, B; GISSLINGER, H; MAYER, J; KRALOVICS, R; POSPISILOVA, S; DOUBEK, M, 2016:Low-Burden TP53 Mutations Occur in Chronic Phase of Myeloproliferative Neoplasms Regardless of Hydroxyurea Administration, Disease Type, and JAK2 Status. BLOOD 128 (22)
• NAVRKALOVA, V; YOUNG, E; BALIAKAS, P; RADOVA, L; SUTTON, LA; PLEVOVA, K; MANSOURI, L; LJUNGSTROM, V; NTOUFA, S; DAVIS, Z; JULIUSSON, G; SMEDBY, KE; BELESSI, C; PANAGIOTIDIS, P; TOULOUMENIDOU, T; DAVI, F; LANGERAK, AW; GHIA, P; STREFFORD, JC; OSCIER, D; MAYER, J; STAMATOPOULOS, K; POSPISILOVA, S; ROSENQUIST, R; TRBUSEK, M, 2016:ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. HAEMATOLOGICA 101 (9)
• POPPOVA, L; JANOVSKA, P; PLEVOVA, K; RADOVA, L; PLESINGEROVA, H; BORSKY, M; KOTASKOVA, J; KANTOROVA, B; HLOZKOVA, M; FIGULOVA, J; BRYCHTOVA, Y; DOUBEK, M; KOZUBIK, A; POSPISILOVA, S; PAVLOVA, S; BRYJA, V, 2016:DECREASED EXPRESSION OF WNT3, A CANONICAL WNT PATHWAY LIGAND, IS FREQUENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PROGRESSION AND IDENTIFIES PATIENTS WITH SHORT TREATMENT-FREE SURVIVAL IN MUTATED IGHV SUBSET. HAEMATOLOGICA 101 , p. 423 - 424.
• POPPOVA, L; JANOVSKA, P; PLEVOVA, K; RADOVA, L; PLESINGEROVA, H; BORSKY, M; KOTASKOVA, J; KANTOROVA, B; HLOZKOVA, M; FIGULOVA, J; BRYCHTOVA, Y; MACHALOVA, M; URIK, M; DOUBEK, M; KOZUBIK, A; POSPISILOVA, S; PAVLOVA, S; BRYJA, V, 2016:Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV. BRITISH JOURNAL OF HAEMATOLOGY 175 (5), p. 851 - 859.
• STOKLASOVA, M; KUCHAROVA, H; BURDOVA, A; DREVOJANKOVA, B; SABLATUROVA, T; STRNKOVA, A; TRUHLIKOVA, L; YVONA, B; PANOVSKA, A; PLEVOVA, K; OLTOVA, A; RYTIKOVA, N; PETRICOVA, N; ADAMOVA, D; HEINZOVA, V; ZYGULOVA, I; LASKA, J; ZUCHNICKA, J; BODZASOVA, C; DURAS, J; URBANKOVA, M; JEHLIKOVA, Z; SLEZAK, P; MACUROVA, J; JANEK, D; BOGOCZOVA, E; WROBEL, M; KLODOVA, D; ZETKOVA, Z; BREJCHA, M, 2016:RARE RECURRENT CHROMOSOMAL ABNORMALITIES IN CLL DETECTED BY CONVENTIONAL CYTOGENETICS AFTER STIMULATION WITH CPG-ODN & IL-2 AND FISH. HAEMATOLOGICA 101 , p. 717 - 717.
• SUTTON, LA; YOUNG, E; BALIAKAS, P; HADZIDIMITRIOU, A; MOYSIADIS, T; PLEVOVA, K; ROSSI, D; KMINKOVA, J; STALIKA, E; PEDERSEN, LB; MALCIKOVA, J; AGATHANGELIDIS, A; DAVIS, Z; MANSOURI, L; SCARFO, L; BOUDJOGHRA, M; NAVARRO, A; MUGGEN, AF; YAN, XJ; NGUYEN-KHAC, F; LARRAYOZ, M; PANAGIOTIDIS, P; CHIORAZZI, N; NIEMANN, CU; BELESSI, C; CAMPO, E; STREFFORD, JC; LANGERAK, AW; OSCIER, D; GAIDANO, G; POSPISILOVA, S; DAVI, F; GHIA, P; STAMATOPOULOS, K; ROSENQUIST, R, 2016:Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. HAEMATOLOGICA 101 (8), p. 959 - 967.
• TURCHANINOVA, MA; DAVYDOV, A; BRITANOVA, OV; SHUGAY, M; BIKOS, V; EGOROV, ES; KIRGIZOVA, VI; MERZLYAK, EM; STAROVEROV, DB; BOLOTIN, DA; MAMEDOV, IZ; IZRAELSON, M; LOGACHEVA, MD; KLADOVA, O; PLEVOVA, K; POSPISILOVA, S; CHUDAKOV, DM, 2016:High-quality full-length immunoglobulin profiling with unique molecular barcoding. NATURE PROTOCOLS 11 (9), p. 1599 - 1616.

2015

• AGATHANGELIDIS, A; BYSTRY, V; HADZIDIMITRIOU, A; SUTTON, LA; MINGA, E; KIENLE, D; DAVIS, Z; YAN, XJ; SHANAFELT, T; BOUDJOGRA, M; PLEVOVA, K; GOUNARI, M; XOCHELLI, A; NAVARRO, A; CHATZOULI, M; PEDERSEN, LB; BALIAKAS, P; SCARFO, L; ROSSI, D; VERONESE, S; FACCO, M; BIKOS, V; KARAN-DJURASEVIC, T; PAVLOVIC, S; MANSOURI, L; POIRON, C; CHU, CC; STALIKA, E; GIUDICELLI, V; PANAGIOTIDIS, P; SUDARIKOV, A; ANAGNOSTOPOULOS, A; TRENTIN, L; CATHERWOOD, M; MONTILLO, M; GAIDANO, G; CAMPO, E; GEISLER, CH; LANGERAK, AW; POSPISILOVA, S; LEFRANC, MP; CHIORAZZI, N; OSCIER, D; JELINEK, DF; STILGENBAUER, S; BELESSI, C; DAVI, F; ROSENQUIST, R; GHIA, P; DARZENTAS, N; STAMATOPOULOS, K, 2015:HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE. HAEMATOLOGICA 100 , p. 47 - 48.
• BALIAKAS, P; AGATHANGELIDIS, A; HADZIDIMITRIOU, A; SUTTON, LA; MINGA, E; TSANOUSA, A; SCARFO, L; DAVIS, Z; YAN, XJ; SHANAFELT, T; PLEVOVA, K; SANDBERG, Y; VOJDEMAN, FJ; BOUDJOGRA, M; TZENOU, T; CHATZOULI, M; CHU, CC; VERONESE, S; GARDINER, A; MANSOURI, L; SMEDBY, KE; PEDERSEN, LB; MORENO, D; VAN LOM, K; GIUDICELLI, V; FRANCOVA, HS; NGUYEN-KHAC, F; PANAGIOTIDIS, P; JULIUSSON, G; ANGELIS, L; ANAGNOSTOPOULOS, A; LEFRANC, MP; FACCO, M; TRENTIN, L; CATHERWOOD, M; MONTILLO, M; GEISLER, CH; LANGERAK, AW; POSPISILOVA, S; CHIORAZZI, N; OSCIER, D; JELINEK, DF; DARZENTAS, N; BELESSI, C; DAVI, F; GHIA, P; ROSENQUIST, R; STAMATOPOULOS, K, 2015:Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. BLOOD 125 (5), p. 856 - 859.
• BALIAKAS, P; HADZIDIMITRIOU, A; MATTSSON, M; XOCHELLI, A; SUTTON, LA; MINGA, E; SCARFO, L; ROSSI, D; DAVIS, Z; AGATHANGELIDIS, A; VILLAMOR, N; PARKER, H; KOTASKOVA, J; STALIKA, E; PLEVOVA, K; MANSOURI, L; CORTESE, D; LOPEZ, AN; DELGADO, J; LARRAYOZ, M; ANAGNOSTOPOULOS, A; BELESSI, C; SMEDBY, KE; JULIUSSON, G; STREFFORD, JC; POSPISILOVA, S; OSCIER, D; GAIDANO, G; CAMPO, E; GHIA, P; ROSENQUIST, R; STAMATOPOULOS, K, 2015:REFINING PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH SOMATICALLY HYPERMUTATED B-CELL RECEPTORS: A NOVEL PROGNOSTIC INDEX ON BEHALF OF THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC). HAEMATOLOGICA 100 , p. 52 - 52.
• BALIAKAS, P; PUIGGROS, A; XOCHELLI, A; SUTTON, LA; NGUYEN-KHAC, F; GARDINER, A; PLEVOVA, K; ORTEGA, M; COLLADO, R; GONZALEZ, T; GRANADA, I; LUNO, E; KOTASKOVA, J; DAVIS, Z; ANAGNOSTOPOULOS, A; STREFFORD, J; POSPISILOVA, S; DAVI, F; ATHANASIADOU, A; ROSENQUIST, R; OSCIER, D; SOLA, BE; STAMATOPOULOS, K, 2015:ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE. HAEMATOLOGICA 100 , p. 224 - 224.
• BRAZDILOVA, K; PLEVOVA, K; FRANCOVA, HS; KOCKOVA, H; CHMELIKOVA, M; BORSKY, M; BURCKOVA, K; KANTOROVA, B; TICHY, B; SKABRAHOVA, H; BRYCHTOVA, Y; MAYER, J; DOUBEK, M; POSPISILOVA, S, 2015:Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry. BLOOD 126 (23)
• KANTOROVA, B; MALCIKOVA, J; BRAZDILOVA, K; BORSKY, M; PLEVOVA, K; SMARDOVA, J; TRBUSEK, M; BRYCHTOVA, Y; DOUBEK, M; MAYER, J; POSPISILOVA, S, 2015:Single Cell Analysis Proves the Coexistence of NOTCH1 and TP53 Mutations within the Same Cancer Cells in Patients with Chronic Lymphocytic Leukemia. BLOOD 126 (23)
• KOTASKOVA, J; MALCIKOVA, J; DIVISKOVA, E; PAVLOVA, S; MEJSTRIKOVA, S; VRANOVA, V; PLEVOVA, K; PLESINGEROVA, H; DOUBEK, M; MAYER, J; POSPISILOVA, S, 2015:13Q DELETION IS PREDOMINANT CYTOGENETIC ABERRATION NEWLY AQUIRED DURING CHRONIC LYMPHOCYTIC LEUKEMIA COURSE IRRESPECTIVE OF DISEASE ACTIVITY AND TREATMENT STATUS. HAEMATOLOGICA 100 , p. 417 - 418.
• LJUNGSTROM, V; CORTESE, D; YOUNG, E; PANDZIC, T; MANSOURI, L; PLEVOVA, K; SUTTON, LA; STAVROYIANNI, N; AGATHANGELIDIS, A; ROSSI, D; HOGLUND, M; OSCIER, D; GAIDANO, G; DAVI, F; POTT, C; TRENTIN, L; POSPISILOVA, S; GHIA, P; STAMATOPOULOS, K; SJOBLOM, T; ROSENQUIST, R, 2015:DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION. HAEMATOLOGICA 100 , p. 10 - 11.
• MALCIKOVA, J; STANO-KOZUBIK, K; TICHY, B; KANTOROVA, B; PAVLOVA, S; TOM, N; RADOVA, L; SMARDOVA, J; PARDY, F; DOUBEK, M; BRYCHTOVA, Y; MRAZ, M; PLEVOVA, K; DIVISKOVA, E; OLTOVA, A; MAYER, J; POSPISILOVA, S; TRBUSEK, M, 2015:Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. LEUKEMIA 29 (4), p. 877 - 885.
• MANSOURI, L; SUTTON, LA; LJUNGSTROM, V; BONDZA, S; ARNGARDEN, L; BHOI, S; LARSSON, J; CORTESE, D; KALUSHKOVA, A; PLEVOVA, K; YOUNG, E; GUNNARSSON, R; FALK-SORQVIST, E; LONN, P; MUGGEN, AF; YAN, XJ; SANDER, B; ENBLAD, G; SMEDBY, KE; JULIUSSON, G; BELESSI, C; RUNG, J; CHIORAZZI, N; STREFFORD, JC; LANGERAK, AW; POSPISILOVA, S; DAVI, F; HELLSTROM, M; JERNBERG-WIKLUND, H; GHIA, P; SODERBERG, O; STAMATOPOULOS, K; NILSSON, M; ROSENQUIST, R, 2015:Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia. JOURNAL OF EXPERIMENTAL MEDICINE 212 (6), p. 833 - 843.
• NAVRKALOVA, V; YOUNG, E; BALIAKAS, P; RADOVA, L; PLEVOVA, K; SUTTON, LA; MANSOURI, L; LJUNGSTROM, V; NTOUFA, S; DAVIS, Z; JULIUSSON, G; SMEDBY, KE; BELESSI, C; PANAGIOTIDIS, P; DAVI, F; LANGERAK, AW; GHIA, P; STREFFORD, JC; OSCIER, DG; STAMATOPOULOS, K; POSPISILOVA, S; ROSENQUIST, R; TRBUSEK, M, 2015:ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome. BLOOD 126 (23)
• NOERENBERG, D; YOUNG, E; LJUNGSTROM, V; MANSOURI, L; PLEVOVA, K; BALIAKAS, P; BLAKEMORE, S; ROSSI, D; CLIFFORD, R; NAVRKALOVA, V; SUTTON, LA; SMEDBY, KE; JULIUSSON, G; BELESSI, C; PANAGIOTIDIS, P; CHIORAZZI, N; DAVI, F; LANGERAK, AW; SCHUH, A; GAIDANO, G; STREFFORD, JC; GHIA, P; STAMATOPOULOS, K; POSPISILOVA, S; ZENZ, T; ROSENQUIST, R; DAMM, F, 2015:EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player. BLOOD 126 (23)
• PLESINGEROVA, H; JANOVSKA, P; POPPOVA, L; SHAIK, A; JURCICKOVA, Z; LIBRA, A; PLEVOVA, K; MACHAC, J; SLAPAK, I; PAVLOVA, S; OVESNA, P; KOTASKOVA, J; DOUBEK, M; POSPISILOVA, S; BRYJA, V, 2015:UPREGULATED COBLL1 IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) PATIENTS WITH UNMUTATED IGHV IDENTIFIES A COHORT WITH INFERIOR PROGNOSIS. HAEMATOLOGICA 100 , p. 50 - 50.
• TOM, N; MALCIKOVA, J; RADOVA, L; KANTOROVA, B; PARDY, F; PAVLOVA, S; PAL, K; MRAZ, M; TICHY, B; DOUBEK, M; BRYCHTOVA, Y; PLEVOVA, K; MAYER, J; TRBUSEK, M; POSPISILOVA, S, 2015:MUTATIONS IN THE TP53 GENE SHOW FEATURES OF SOMATIC HYPERMUTATION PROCESS WITH PROMINENT DIFFERENCE BETWEEN IGHV MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA. HAEMATOLOGICA 100 , p. 224 - 225.

2014

• BALIAKAS, P; HADZIDIMITRIOU, A; SUTTON, LA; MINGA, E; AGATHANGELIDIS, A; TSANOUSA, A; SCARFO, L; DAVIS, Z; YAN, J; SHANAFELT, TD; PLEVOVA, K; SANDBERG, Y; VOJDEMAN, FJ; BOUDJOGHRA, M; TZENOU, T; CHATZOULI, M; CHU, CC; VERONESE, S; GARDINER, AC; MANSOURI, L; SMEDBY, KE; PEDERSEN, L; MORENO, D; VAN LOM, K; GIUDICELLI, V; FRANCOVA, H; NGUYEN-KHAC, F; PANAGIOTIDIS, P; JULIUSSON, G; ANGELIS, L; ANAGNOSTOPOULOS, A; LEFRANC, MP; FACCO, M; TRENTIN, L; CATHERWOOD, M; MONTILLO, M; GEISLER, CH; LANGERAK, AW; POSPISILOVA, S; CHIORAZZI, N; OSCIER, D; JELINEK, DF; DARZENTAS, N; BELESSI, C; DAVI, F; ROSENQUIST, R; GHIA, P; STAMATOPOULOS, K, 2014:Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia. BLOOD 124 (21)
• SHUGAY, M; BRITANOVA, OV; MERZLYAK, EM; TURCHANINOVA, MA; MAMEDOV, IZ; TUGANBAEV, TR; BOLOTIN, DA; STAROVEROV, DB; PUTINTSEVA, EV; PLEVOVA, K; LINNEMANN, C; SHAGIN, D; POSPISILOVA, S; LUKYANOV, S; SCHUMACHER, TN; CHUDAKOV, DM, 2014:Towards error-free profiling of immune repertoires. NATURE METHODS 11 (6), p. 653 - +.
• XOCHELLI, A; KAVAKIOTIS, I; AGATHANGELIDIS, A; KIENLE, D; DAVIS, Z; YAN, XJ; SHANAFELT, T; BOUDJOGRA, M; PLEVOVA, K; CHATZOULI, M; PEDERSEN, LB; VERONESE, S; FACCO, M; MORENO, D; CHU, CC; GIUDICELLI, V; PANAGIOTIDIS, P; VLAHAVAS, I; ANAGNOSTOPOULOS, A; MAGLAVERAS, N; TRENTIN, L; CATHERWOOD, M; MONTILLO, M; GEISLER, CH; LANGERAK, AW; POSPISILOVA, S; LEFRANC, MP; CHIORAZZI, N; OSCIER, D; JELINEK, DF; STILGENBAUER, S; BELESSI, C; GHIA, P; DAVI, F; ROSENQUIST, R; DARZENTAS, N; CHOUVARDA, I; SUTTON, LA; HADZIDIMITRIOU, A; STAMATOPOULOS, K, 2014:Charting Unique Signatures of Somatic Hypermutation Amongst Chronic Lymphocytic Leukemia Patients Expressing IGHV4-34 Clonotypic B Cell Receptors. BLOOD 124 (21)